Pfizer Inc (NYSE:PFE)

27.93
Data as of Oct 20
 +0.10 / +0.36%
Today’s Change
27.51
Today|||52-Week Range
32.96
-8.81%
Year-to-Date
Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog
Oct 20 / Zacks.com
A Quick Look at Pfizer Inc.'s Drug Development Pipeline
Oct 14 / MotleyFool.com
M&A Deals Fail At Highest Rate Since 2008
Oct 20 / Investing Channel
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
Oct 14 / MotleyFool.com
Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet
Oct 20 / TheStreet.com
Where Will Celgene Corporation Stock Be a Year From Now?
Oct 14 / MotleyFool.com
3 Stocks Reiterated As A Buy: PFE, MU, CELG
Oct 20 / TheStreet.com
Ireland's Double Irish faces its demise
Oct 14 / FT.com
Dow Jones (DJIA) Today: Pfizer (PFE) Lower
Oct 20 / TheStreet.com
Steris makes UK tax leap with $1.9bn Synergy inversion deal
Oct 13 / FT.com
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Oct 20 / MotleyFool.com
Will Johnson & Johnson Beat Earnings on Pharma Sales? - Analyst Blog
Oct 13 / Zacks.com
M&A deal failure at highest since 2008
Oct 19 / FT.com
The Next Biotech Buyout Stock
Oct 10 / MotleyFool.com
How to Buy Stocks That Can Make Your Kids Rich
Oct 19 / MotleyFool.com
The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock
Oct 07 / MotleyFool.com
Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
Oct 18 / MotleyFool.com
Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
Oct 07 / MotleyFool.com
UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda
Oct 17 / Benzinga
Breaking up is the latest Wall Street craze
Oct 06 / CNNMoney.com
Pfizer's AstraZeneca pursuit knocked by Shire deal collapse
Oct 17 / FT.com
BD agrees to buy CareFusion for $12.2bn
Oct 05 / FT.com
3 Stocks Dragging In The Drugs Industry
Oct 16 / TheStreet.com
Cork brushes off Apple tax claims
Oct 03 / FT.com
3 Small-Cap Biotech Stocks to Buy if the Market Crashes
Oct 15 / MotleyFool.com
Salix pulls deal amid US tax crackdown
Oct 03 / FT.com
AbbVie drops B#32bn bombshell on Shire
Oct 15 / FT.com
Top 10 companies lobbying Washington
Oct 01 / CNNMoney.com
Pfizer Inc. (PFE): Why You Should Sell the Stock
Oct 15 / Investing Channel
Multibillion cross-border deals make a return after five years
Sep 30 / FT.com
AbbVie Backs Away From Shire Takeover After Tax Changes
Oct 15 / TheStreet.com
Bonus clawbacks will burnish City prestige, not tarnish it
Sep 29 / FT.com
Johnson & Johnson and Bristol-Myers Squibbbs New Collaboration Just the Tip of the Ic...
Oct 15 / MotleyFool.com
CarMax declines on disappointing sales
Sep 23 / FT.com
FDA Sends Mixed Message On Safety of Pfizer inc.'s Chantix
Oct 15 / MotleyFool.com
U.S. move on tax-dodging mergers hits drugs stocks
Sep 23 / CNNMoney.com
Shire: Inversions row should not (hop)scotch tax competition
Oct 15 / FT.com
Tax inversion crackdown hits drugmaker shares
Sep 23 / FT.com
European Stocks Fall on Continued Worries Over Eurozone Economy
Oct 15 / TheStreet.com
Stocks: 4 things to know before the open
Sep 23 / CNNMoney.com
Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
Oct 14 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.